tiprankstipranks
The Fly

Evolent Health price target lowered to $27 from $43 at JMP Securities

Evolent Health price target lowered to $27 from $43 at JMP Securities

JMP Securities analyst Constantine Davides lowered the firm’s price target on Evolent Health (EVH) to $27 from $43 and keeps a Market Perform rating on the shares following Q3 results. Negative prior-period developments for claims processed from September through early November drove $24M of higher-than-expected costs, while the cost trend that accelerated in August and September drove an additional $18M in unexpected Q3 medical expenses, primarily within the company’s oncology line, JMP told investors.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1